| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/18/1996 | DE4425115A1 Verfahren zur Modifizierung der Stabilität von Antikörpern A method for modifying the stability of antibodies |
| 01/18/1996 | DE4424828A1 Neue substituierte Arylsulfonamide, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted aryl sulfonamides, their preparation and their use as medicaments |
| 01/18/1996 | DE4424577A1 Transporter protein for cationic xenobiotic(s) and pharmaceuticals, and related DNA and transformed cells |
| 01/18/1996 | CA2194403A1 Use of igf-i or analogues thereof in the prevention of diabetes |
| 01/18/1996 | CA2194396A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
| 01/18/1996 | CA2194391A1 Human elastase iv |
| 01/18/1996 | CA2194390A1 Serum paraoxonase |
| 01/18/1996 | CA2194239A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 01/18/1996 | CA2194237A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | CA2194057A1 Factor to grow tissue ex vivo |
| 01/18/1996 | CA2193988A1 Combination treatment as animal growth promoter containing bovine somatotropin and an estrogenic agent |
| 01/18/1996 | CA2193685A1 Screening for nuc inhibitors |
| 01/18/1996 | CA2193399A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/18/1996 | CA2193226A1 Use of insulin and igf-i |
| 01/18/1996 | CA2192565A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/18/1996 | CA2191696A1 Cancer therapy using lymphotoxin |
| 01/17/1996 | EP0692535A1 Oligonucleotides to inhibit the role of isoprenyl protein transferases |
| 01/17/1996 | EP0692490A2 Recombinant Alzheimer's amyloid protein protease inhibitor |
| 01/17/1996 | EP0692489A1 Preparation of stable zinc insulin analog crystals |
| 01/17/1996 | EP0692488A2 Interleukin 4 signal transducers and binding assays |
| 01/17/1996 | EP0692259A2 Use of HCG-specific antibody for the treatment of brain neoplasms |
| 01/17/1996 | EP0692258A1 Periwinkle seed extract and composition containing it |
| 01/17/1996 | EP0692251A1 Use of methotrexate for the manufacture of a medicament for the treatment of lung capillary leak |
| 01/17/1996 | EP0692032A1 Suppressor of hiv replication and transcription |
| 01/17/1996 | EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 01/17/1996 | EP0692028A1 Pharmaceuticals based on papillomaviruses |
| 01/17/1996 | EP0692024A1 AN $g(a)-GALACTOSIDASE ENZYME |
| 01/17/1996 | EP0691989A1 Biologically active polypeptide fusion dimers |
| 01/17/1996 | EP0691988A1 Inhibitor of stem cell proliferation and uses thereof |
| 01/17/1996 | EP0691987A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 01/17/1996 | EP0691986A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS |
| 01/17/1996 | EP0691985A1 Phosphonomethyldipeptides |
| 01/17/1996 | EP0691984A1 Purification of factor vii |
| 01/17/1996 | EP0691854A1 Conjugates of proteins and bifunctional ligands |
| 01/17/1996 | EP0691852A1 Prodrugs with enhanced penetration into cells |
| 01/17/1996 | EP0691851A1 A method to produce a substance to inhibit cell penetration, and a contraceptive to prevent conception, and a thrombus, prostate and aids vaccine and medicine |
| 01/17/1996 | EP0691850A1 Factor xiii for treatment of skin wounds |
| 01/17/1996 | EP0691849A1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d |
| 01/17/1996 | EP0691847A1 Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion |
| 01/17/1996 | EP0691844A1 Method for treating amyloidosis |
| 01/17/1996 | EP0674646A4 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use. |
| 01/17/1996 | EP0577659B1 Cross-linking agent |
| 01/17/1996 | EP0554381B1 Use of protective agents against reactive oxygen species |
| 01/17/1996 | EP0552202B1 Methods mediated by the proto-oncogenic protein complex AP-1 |
| 01/17/1996 | EP0521916B1 Use of il-4 to enhance immune response to infectious antigenic challenges |
| 01/17/1996 | EP0493480B1 Dehydrodidemnin b |
| 01/17/1996 | EP0436526B1 Use of antibodies to angiogenin: immunotherapeutic agents |
| 01/17/1996 | EP0314705B1 A novel family of primate hematopoietic growth factors |
| 01/17/1996 | CN2217414Y Human-blood albumin heat-treatment box |
| 01/17/1996 | CN1115182A Antithrombotic |
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
| 01/17/1996 | CN1114875A "Interleukin" specific skin-nursing product |
| 01/17/1996 | CN1030718C Superoxide dismutase |
| 01/17/1996 | CN1030703C Neurokinin A antagonists |
| 01/16/1996 | US5484917 For treatment and prevention of gastrointestinal disorders, pain and anxiety |
| 01/16/1996 | US5484907 Nucleotides coding for the extracellular membrane-bound segment of IgA |
| 01/16/1996 | US5484892 Monoclonal antibodies that block ligand binding to the CD22 receptor in mature B cells |
| 01/16/1996 | US5484891 Pure polypeptide able to hybridize under low stringency conditions; glycoproteins |
| 01/16/1996 | US5484890 Antihemophilic factor stabilization |
| 01/16/1996 | US5484889 Plant protein useful for treating tumors and HIV infection |
| 01/16/1996 | US5484885 Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37 |
| 01/16/1996 | US5484777 Pancreatic cholesterol esterase inhibitor |
| 01/16/1996 | US5484772 Arginine aldehyde compounds as anticoagulants or treatment of thromboembolitic agents |
| 01/16/1996 | US5484771 Ribonucleotide reductase inhibitors |
| 01/16/1996 | US5484770 Peptide compounds which inhibit the proliferation of epidermal or epithelial stem cells |
| 01/16/1996 | US5484768 Treatment of male infertility by administration of a muellerian inhibiting substance and surgery and/or hormonal treatment |
| 01/16/1996 | US5484767 Substantially pure steroidogenesis inducing protein and uses thereof |
| 01/16/1996 | US5484727 Cloned gene encoding acylcoenzyme A: cholesterol acyltransferase (ACAT) |
| 01/16/1996 | US5484726 Contacting with labelled antibody or fragment that binds it and detection; medical diagnosis of malignant breast cancer |
| 01/16/1996 | US5484724 DNA encoding GLSI |
| 01/16/1996 | US5484711 DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI |
| 01/16/1996 | US5484609 Therapeutic compositions and methods |
| 01/16/1996 | US5484596 Active specific immunotherapy |
| 01/16/1996 | US5484591 Method for treating gram negative bacterial infections in humans |
| 01/16/1996 | US5484590 Expression of the developmental I antigen by a cloned human cDNA encoding a member of a β-1,6-N-acetylglucosaminyltransferase gene family |
| 01/16/1996 | US5484589 Treating a dog infected by a canine virus |
| 01/16/1996 | CA1337935C Antibiotic derived from bacillus subtilis strains ncib 12375, 12376 and 12616 and related strains |
| 01/14/1996 | CA2153720A1 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
| 01/11/1996 | WO1996000790A1 Adenovirus including a gene coding for a superoxide dismutase |
| 01/11/1996 | WO1996000739A1 Modified g-protein coupled receptors |
| 01/11/1996 | WO1996000738A1 Endothelin antagonists ii |
| 01/11/1996 | WO1996000737A1 Cytokines supporting progenitor proliferation, progenitor differentiation or platelet formation |
| 01/11/1996 | WO1996000736A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 01/11/1996 | WO1996000587A1 Aav capsid vehicles for molecular transfer |
| 01/11/1996 | WO1996000586A2 Methods for treating cell proliferative disorders by modulating signal transduction |
| 01/11/1996 | WO1996000582A1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 01/11/1996 | WO1996000581A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 01/11/1996 | WO1996000577A1 Agents affecting thrombosis hemostasis |
| 01/11/1996 | WO1996000575A1 Polynucleoside chain having multiple nucleosides, the nucleosides coupled by guanidyl linkages |
| 01/11/1996 | WO1996000573A1 Compositions for enhancing immune function |
| 01/11/1996 | WO1996000506A1 Stabilized composition comprising colistin sulfate |
| 01/11/1996 | WO1996000503A1 Novel peptides |
| 01/11/1996 | WO1995033759A3 Antisense oligonucleotides and methods for the treatment of schistosomiasis |
| 01/11/1996 | WO1995031559A3 Methods of inducing gene expression by ionizing radiation |
| 01/11/1996 | WO1995031552A3 Human papilloma virus inhibition by a hairpin ribozyme |
| 01/11/1996 | WO1995030001A3 Novel p-selectin ligand protein |
| 01/11/1996 | DE4425857A1 Kaskaden-Polymer-Komplexe, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Mittel Cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them |
| 01/11/1996 | DE4423574A1 Nicht-glykosylierte Plasminogenaktivator-Derivate und ihre Verwendung bei erhöhtem Blutungsrisiko Non-glycosylated plasminogen activator derivatives and their use in increased risk of bleeding |
| 01/11/1996 | DE4423392A1 Verfahren zur Identifizierung antigener Peptide A method for identifying antigenic peptides |
| 01/11/1996 | CA2193828A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |